Dashboard
Manage Tickers

CECelanese Corp

NYSE celanese.com


$ 158.11 $ -1.60 (-1 %)    

Wednesday, 15-May-2024 14:39:55 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 452.63 $ 3.71 (0.83 %)
DIA $ 398.39 $ 0.51 (0.13 %)
SPY $ 528.88 $ 2.96 (0.56 %)
TLT $ 92.00 $ 0.16 (0.17 %)
GLD $ 220.68 $ 1.44 (0.66 %)
$ 159.71
$ 161.03
$ 157.90 x 112
$ 158.21 x 100
$ 158.01 - $ 161.05
$ 98.72 - $ 171.38
675,955
na
17.49B
$ 1.36
$ 8.79
TBD
na
na ($ 0.02)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-10-2024 03-31-2024 10-Q
2 02-23-2024 12-31-2023 10-K
3 11-08-2023 09-30-2023 10-Q
4 08-08-2023 06-30-2023 10-Q
5 05-10-2023 03-31-2023 10-Q
6 02-24-2023 12-31-2022 10-K
7 11-04-2022 09-30-2022 10-Q
8 07-29-2022 06-30-2022 10-Q
9 04-29-2022 03-31-2022 10-Q
10 02-10-2022 12-31-2021 10-K
11 10-22-2021 09-30-2021 10-Q
12 07-23-2021 06-30-2021 10-Q
13 04-23-2021 03-31-2021 10-Q
14 02-11-2021 12-31-2020 10-K
15 10-26-2020 09-30-2020 10-Q
16 07-29-2020 06-30-2020 10-Q
17 04-28-2020 03-31-2020 10-Q
18 02-06-2020 12-31-2019 10-K
19 10-22-2019 09-30-2019 10-Q
20 07-23-2019 06-30-2019 10-Q
21 04-23-2019 03-31-2019 10-Q
22 02-07-2019 12-31-2018 10-K
23 10-19-2018 09-30-2018 10-Q
24 07-20-2018 06-30-2018 10-Q
25 04-17-2018 03-31-2018 10-Q
26 02-09-2018 12-31-2017 10-K
27 10-17-2017 09-30-2017 10-Q
28 07-25-2017 06-30-2017 10-Q
29 04-18-2017 03-31-2017 10-Q
30 02-10-2017 12-31-2016 10-K
31 10-18-2016 09-30-2016 10-Q
32 07-26-2016 06-30-2016 10-Q
33 04-19-2016 03-31-2016 10-Q
34 02-05-2016 12-31-2015 10-K
35 10-20-2015 09-30-2015 10-Q
36 07-17-2015 06-30-2015 10-Q
37 04-17-2015 03-31-2015 10-Q
38 02-06-2015 12-31-2014 10-K
39 10-21-2014 09-30-2014 10-Q
40 07-18-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

bmo-capital-maintains-market-perform-on-celanese-raises-price-target-to-158
BMO Capital Maintains Market Perform on Ce...
05/14/2024 15:28:10

BMO Capital analyst John McNulty maintains Celanese (NYSE:CE) with a Market Perform and raises the price target from $153 to...

rbc-capital-maintains-outperform-on-celanese-raises-price-target-to-176
RBC Capital Maintains Outperform on Celane...
05/13/2024 14:45:45

RBC Capital analyst Arun Viswanathan maintains Celanese (NYSE:CE) with a Outperform and raises the price target from $171 to...

celanese-to-rally-around-12-here-are-10-top-analyst-forecasts-for-friday
Celanese To Rally Around 12%? Here Are 10 ...
05/10/2024 12:25:35

baird-maintains-outperform-on-celanese-raises-price-target-to-180
Baird Maintains Outperform on Celanese, Ra...
05/10/2024 11:25:00

Baird analyst Ghansham Panjabi maintains Celanese (NYSE:CE) with a Outperform and raises the price target from $165 to $180.

the-analyst-verdict-celanese-in-the-eyes-of-11-experts
The Analyst Verdict: Celanese In The Eyes ...
05/09/2024 14:00:27

mizuho-maintains-neutral-on-celanese-raises-price-target-to-173
Mizuho Maintains Neutral on Celanese, Rais...
05/09/2024 11:49:49

Mizuho analyst Kieran De Brun maintains Celanese (NYSE:CE) with a Neutral and raises the price target from $161 to $173.

celanese-sees-q2-adj-eps-260-300-vs-292-est
Celanese Sees Q2 Adj. EPS $2.60-$3.00 vs $...
05/08/2024 20:17:30

celanese-q1-2024-adj-eps-208-beats-191-estimate-sales-2611b-miss-2674b-estimate
Celanese Q1 2024 Adj EPS $2.08 Beats $1.91...
05/08/2024 20:16:39

Celanese (NYSE:CE) reported quarterly earnings of $2.08 per share which beat the analyst consensus estimate of $1.91 by 8.9 per...

rbc-capital-maintains-outperform-on-celanese-raises-price-target-to-171
RBC Capital Maintains Outperform on Celane...
04/19/2024 17:44:42

RBC Capital analyst Arun Viswanathan maintains Celanese (NYSE:CE) with a Outperform and raises the price target from $165 to...

how-is-the-market-feeling-about-celanese
How Is The Market Feeling About Celanese?
04/12/2024 16:45:26

citigroup-maintains-neutral-on-celanese-raises-price-target-to-167
Citigroup Maintains Neutral on Celanese, R...
04/10/2024 17:51:32

Citigroup analyst Patrick Cunningham maintains Celanese (NYSE:CE) with a Neutral and raises the price target from $150 to $167.

a-closer-look-at-11-analyst-recommendations-for-celanese
A Closer Look at 11 Analyst Recommendation...
04/09/2024 13:00:27

keybanc-maintains-overweight-on-celanese-raises-price-target-to-190
Keybanc Maintains Overweight on Celanese, ...
04/09/2024 08:42:05

Keybanc analyst Aleksey Yefremov maintains Celanese (NYSE:CE) with a Overweight and raises the price target from $176 to $190.

barclays-downgrades-celanese-to-equal-weight-maintains-price-target-to-170
Barclays Downgrades Celanese to Equal-Weig...
04/04/2024 13:19:29

Barclays analyst Michael Leithead downgrades Celanese (NYSE:CE) from Overweight to Equal-Weight and maintains the price targ...

jp-morgan-downgrades-celanese-to-underweight-raises-price-target-to-160
JP Morgan Downgrades Celanese to Underweig...
04/04/2024 11:32:39

JP Morgan analyst Jeffrey Zekauskas downgrades Celanese (NYSE:CE) from Neutral to Underweight and raises the price target fr...

1000-invested-in-celanese-15-years-ago-would-be-worth-this-much-today
$1000 Invested In Celanese 15 Years Ago Wo...
04/01/2024 15:00:28

9-analysts-assess-celanese-what-you-need-to-know
9 Analysts Assess Celanese: What You Need ...
03/22/2024 16:00:16

wells-fargo-maintains-overweight-on-celanese-raises-price-target-to-195
Wells Fargo Maintains Overweight on Celane...
03/22/2024 15:37:43

Wells Fargo analyst Michael Sison maintains Celanese (NYSE:CE) with a Overweight and raises the price target from $180 to $195.

celanese-and-secarna-pharmaceuticals-enter-rna-research-collaboration-for-long-acting-antisense-therapies
Celanese and Secarna Pharmaceuticals Enter...
03/20/2024 13:03:22

heres-how-much-1000-invested-in-celanese-15-years-ago-would-be-worth-today
Here's How Much $1000 Invested In Celanese...
03/15/2024 14:00:18

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION